+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bio-pharma Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 97 Pages
  • January 2025
  • Region: Global
  • Prof Research
  • ID: 5772830
The bio-pharma market represents a critical segment within the healthcare industry, focusing on developing, manufacturing, and marketing pharmaceuticals derived from living organisms. This sector has witnessed significant advancements driven by technological innovations, an increasing prevalence of chronic diseases, and growing demand for biologics and biosimilars. As of 2023, the global bio-pharma market was valued at approximately $400 billion and is projected to grow at a compound annual growth rate (CAGR) of 6% to 8% from 2024 to 2029, reaching an estimated $600 billion by 2029.

Market Size, Share & Trends Analysis

By Product Type

The bio-pharma market can be segmented by product type into the following categories:
  • Monoclonal Antibodies: This segment has dominated the market due to their efficacy in treating various conditions, especially cancers and autoimmune diseases. It holds about 30% of the market share.
  • Interferon: Used primarily for viral infections and specific types of cancer, interferons account for around 10% of the market.
  • Insulin: With the rise of diabetes globally, this segment has captured approximately 12% of the market share, highlighting the ongoing demand for diabetes management solutions.
  • Growth and Coagulation Factors: These products represent about 8% of the market, commonly used in treating hemophilia and other bleeding disorders.
  • Erythropoietin: This product type is crucial for anemia treatment, holding about 5% market share.
  • Vaccines: With newfound focus due to the COVID-19 pandemic, vaccines constitute approximately 15% of the market share.
  • Hormones: Essential for various biological functions, these account for about 7% of the market.
  • Others: This catch-all category, which includes various other biologics, holds around 13% of the market share.

By Key Players

Leading companies in the bio-pharma market include:
  • AstraZeneca
  • Eli Lilly
  • Bayer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novartis
  • Merck & Co.
  • Bristol-Myers Squibb
  • Pfizer
  • AbbVie
  • Roche
  • Sanofi
  • Amgen
  • Biogen
These players are engaging in strategic partnerships, mergers, and acquisitions to bolster their market presence and expand their product portfolios.

By Process

The bio-pharma market is also analyzed by the processes used, which include:
  • Recombinant DNA Technology
  • Monoclonal Antibody Technology
  • Cell Culture Technology
  • Fermentation Technology
  • Others

By Application

By application, the market segments include:
  • Oncology: This application represents the largest share, accounting for about 25% of the market.
  • Blood Disorder: This segment captures around 5% of the bio-pharma market.
  • Metabolic Disease: This section, including diabetes treatments, constitutes 12%.
  • Infectious Disease: With ongoing pandemics and antibiotic resistance, this area holds about 18%.
  • Cardiovascular Disease: Accounting for approximately 15%.
  • Neurological Disease: This category covers around 10% of the market.
  • Immunology: This growing field represents about 5%.
  • Others: Comprising various other medical conditions, this segment holds 10%.

By End-Use

End-use analysis reveals that hospitals are the primary consumers, utilizing bio-pharmaceutical products significantly more than outpatient clinics or research institutions, with hospitals holding a market share of 55%.

By Region

Geographical analysis shows the following insights:
  • North America: This region dominates the market with a share of 45%, attributed to advanced healthcare infrastructure and strong R&D activities.
  • Europe: Comprising approximately 30% of the market, driven by governmental support in drug development.
  • Asia-Pacific: Expected to be the fastest-growing region with a CAGR of 8% to 10%, partly fueled by rising healthcare expenditures and increasing patient populations.
  • Latin America and Middle East & Africa: These regions account for 15% and 10% of the market, respectively, showing potential for growth owing to increasing access to healthcare services.

Market News on Policy and Companies

Regulatory bodies globally are pushing for quicker approval processes for bio-pharmaceuticals. Initiatives such as the FDA's accelerated approval pathway in the United States and similar programs in Europe are facilitating faster registrations. This pro-biopharma policy environment is essential in ensuring that innovative therapies reach patients in a timely manner.

Segment Forecasts, 2024 - 2029

For the forecast period from 2024 to 2029, the bio-pharma market is expected to exhibit robust growth across segments:
  • Monoclonal Antibodies: Anticipated to continue dominating the market, growing at a CAGR of 7% to 9%.
  • Vaccines: Expected to see a surge in demand, particularly in response to emerging infectious diseases, with a CAGR of 8% to 10%.
  • Growth and Coagulation Factors: This segment will likely grow at around 5% to 7%.
  • Cell Culture Technology: Projected to grow significantly, with a CAGR of 9% to 12%.
  • Oncology Applications: Predicted to continuously be a leading area with a CAGR of 8% to 10%.
  • Geographical Expansion in Asia-Pacific: Expected to increase its market share with a CAGR over 10%.
In conclusion, the bio-pharma market presents immense opportunities due to ongoing innovations, a supportive regulatory environment, and increasing global health challenges. Stakeholders are encouraged to stay abreast of market dynamics, as these factors will influence investment and strategic planning decisions through 2029.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Bio-Pharma Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Bio-Pharma Market in North America (2020-2030)
8.1 Bio-Pharma Market Size
8.2 Bio-Pharma Market by End Use
8.3 Competition by Players/Suppliers
8.4 Bio-Pharma Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Bio-Pharma Market in South America (2020-2030)
9.1 Bio-Pharma Market Size
9.2 Bio-Pharma Market by End Use
9.3 Competition by Players/Suppliers
9.4 Bio-Pharma Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Bio-Pharma Market in Asia & Pacific (2020-2030)
10.1 Bio-Pharma Market Size
10.2 Bio-Pharma Market by End Use
10.3 Competition by Players/Suppliers
10.4 Bio-Pharma Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Bio-Pharma Market in Europe (2020-2030)
11.1 Bio-Pharma Market Size
11.2 Bio-Pharma Market by End Use
11.3 Competition by Players/Suppliers
11.4 Bio-Pharma Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Bio-Pharma Market in MEA (2020-2030)
12.1 Bio-Pharma Market Size
12.2 Bio-Pharma Market by End Use
12.3 Competition by Players/Suppliers
12.4 Bio-Pharma Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Bio-Pharma Market (2020-2025)
13.1 Bio-Pharma Market Size
13.2 Bio-Pharma Market by End Use
13.3 Competition by Players/Suppliers
13.4 Bio-Pharma Market Size by Type
Chapter 14 Global Bio-Pharma Market Forecast (2025-2030)
14.1 Bio-Pharma Market Size Forecast
14.2 Bio-Pharma Application Forecast
14.3 Competition by Players/Suppliers
14.4 Bio-Pharma Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca
15.1.1 Company Profile
15.1.2 Main Business and Bio-pharma Information
15.1.3 SWOT Analysis of AstraZeneca
15.1.4 AstraZeneca Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and Bio-pharma Information
15.2.3 SWOT Analysis of Eli Lilly
15.2.4 Eli Lilly Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.3 Bayer
15.3.1 Company Profile
15.3.2 Main Business and Bio-pharma Information
15.3.3 SWOT Analysis of Bayer
15.3.4 Bayer Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.4 Johnson & Johnson
15.4.1 Company Profile
15.4.2 Main Business and Bio-pharma Information
15.4.3 SWOT Analysis of Johnson & Johnson
15.4.4 Johnson & Johnson Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.5 GlaxoSmithKline
15.5.1 Company Profile
15.5.2 Main Business and Bio-pharma Information
15.5.3 SWOT Analysis of GlaxoSmithKline
15.5.4 GlaxoSmithKline Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.6 Novartis Merck & Co.
15.6.1 Company Profile
15.6.2 Main Business and Bio-pharma Information
15.6.3 SWOT Analysis of Novartis Merck & Co.
15.6.4 Novartis Merck & Co. Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.7 Bristol-Myers Squibb
15.7.1 Company Profile
15.7.2 Main Business and Bio-pharma Information
15.7.3 SWOT Analysis of Bristol-Myers Squibb
15.7.4 Bristol-Myers Squibb Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.8 Pfizer
15.8.1 Company Profile
15.8.2 Main Business and Bio-pharma Information
15.8.3 SWOT Analysis of Pfizer
15.8.4 Pfizer Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.9 AbbVie
15.9.1 Company Profile
15.9.2 Main Business and Bio-pharma Information
15.9.3 SWOT Analysis of AbbVie
15.9.4 AbbVie Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.10 Roche
15.10.1 Company Profile
15.10.2 Main Business and Bio-pharma Information
15.10.3 SWOT Analysis of Roche
15.10.4 Roche Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.11 Sanofi
15.11.1 Company Profile
15.11.2 Main Business and Bio-pharma Information
15.11.3 SWOT Analysis of Sanofi
15.11.4 Sanofi Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.12 Amgen
15.12.1 Company Profile
15.12.2 Main Business and Bio-pharma Information
15.12.3 SWOT Analysis of Amgen
15.12.4 Amgen Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
15.13 Biogen
15.13.1 Company Profile
15.13.2 Main Business and Bio-pharma Information
15.13.3 SWOT Analysis of Biogen
15.13.4 Biogen Bio-pharma Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Bio-Pharma Report
Table Data Sources of Bio-Pharma Report
Table Major Assumptions of Bio-Pharma Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Bio-Pharma Picture
Table Bio-Pharma Classification
Table Bio-Pharma Applications
Table Drivers of Bio-Pharma Market
Table Restraints of Bio-Pharma Market
Table Opportunities of Bio-Pharma Market
Table Threats of Bio-Pharma Market
Table COVID-19 Impact For Bio-Pharma Market
Table Raw Materials Suppliers
Table Different Production Methods of Bio-Pharma
Table Cost Structure Analysis of Bio-Pharma
Table Key End Users
Table Latest News of Bio-Pharma Market
Table Merger and Acquisition
Table Planned/Future Project of Bio-Pharma Market
Table Policy of Bio-Pharma Market
Table 2020-2030 North America Bio-Pharma Market Size
Figure 2020-2030 North America Bio-Pharma Market Size and CAGR
Table 2020-2030 North America Bio-Pharma Market Size by Application
Table 2020-2025 North America Bio-Pharma Key Players Revenue
Table 2020-2025 North America Bio-Pharma Key Players Market Share
Table 2020-2030 North America Bio-Pharma Market Size by Type
Table 2020-2030 United States Bio-Pharma Market Size
Table 2020-2030 Canada Bio-Pharma Market Size
Table 2020-2030 Mexico Bio-Pharma Market Size
Table 2020-2030 South America Bio-Pharma Market Size
Figure 2020-2030 South America Bio-Pharma Market Size and CAGR
Table 2020-2030 South America Bio-Pharma Market Size by Application
Table 2020-2025 South America Bio-Pharma Key Players Revenue
Table 2020-2025 South America Bio-Pharma Key Players Market Share
Table 2020-2030 South America Bio-Pharma Market Size by Type
Table 2020-2030 Brazil Bio-Pharma Market Size
Table 2020-2030 Argentina Bio-Pharma Market Size
Table 2020-2030 Chile Bio-Pharma Market Size
Table 2020-2030 Peru Bio-Pharma Market Size
Table 2020-2030 Asia & Pacific Bio-Pharma Market Size
Figure 2020-2030 Asia & Pacific Bio-Pharma Market Size and CAGR
Table 2020-2030 Asia & Pacific Bio-Pharma Market Size by Application
Table 2020-2025 Asia & Pacific Bio-Pharma Key Players Revenue
Table 2020-2025 Asia & Pacific Bio-Pharma Key Players Market Share
Table 2020-2030 Asia & Pacific Bio-Pharma Market Size by Type
Table 2020-2030 China Bio-Pharma Market Size
Table 2020-2030 India Bio-Pharma Market Size
Table 2020-2030 Japan Bio-Pharma Market Size
Table 2020-2030 South Korea Bio-Pharma Market Size
Table 2020-2030 Southeast Asia Bio-Pharma Market Size
Table 2020-2030 Australia Bio-Pharma Market Size
Table 2020-2030 Europe Bio-Pharma Market Size
Figure 2020-2030 Europe Bio-Pharma Market Size and CAGR
Table 2020-2030 Europe Bio-Pharma Market Size by Application
Table 2020-2025 Europe Bio-Pharma Key Players Revenue
Table 2020-2025 Europe Bio-Pharma Key Players Market Share
Table 2020-2030 Europe Bio-Pharma Market Size by Type
Table 2020-2030 Germany Bio-Pharma Market Size
Table 2020-2030 France Bio-Pharma Market Size
Table 2020-2030 United Kingdom Bio-Pharma Market Size
Table 2020-2030 Italy Bio-Pharma Market Size
Table 2020-2030 Spain Bio-Pharma Market Size
Table 2020-2030 Belgium Bio-Pharma Market Size
Table 2020-2030 Netherlands Bio-Pharma Market Size
Table 2020-2030 Austria Bio-Pharma Market Size
Table 2020-2030 Poland Bio-Pharma Market Size
Table 2020-2030 Russia Bio-Pharma Market Size
Table 2020-2030 MEA Bio-Pharma Market Size
Figure 2020-2030 MEA Bio-Pharma Market Size and CAGR
Table 2020-2030 MEA Bio-Pharma Market Size by Application
Table 2020-2025 MEA Bio-Pharma Key Players Revenue
Table 2020-2025 MEA Bio-Pharma Key Players Market Share
Table 2020-2030 MEA Bio-Pharma Market Size by Type
Table 2020-2030 Egypt Bio-Pharma Market Size
Table 2020-2030 Israel Bio-Pharma Market Size
Table 2020-2030 South Africa Bio-Pharma Market Size
Table 2020-2030 Gulf Cooperation Council Countries Bio-Pharma Market Size
Table 2020-2030 Turkey Bio-Pharma Market Size
Table 2020-2025 Global Bio-Pharma Market Size by Region
Table 2020-2025 Global Bio-Pharma Market Size Share by Region
Table 2020-2025 Global Bio-Pharma Market Size by Application
Table 2020-2025 Global Bio-Pharma Market Share by Application
Table 2020-2025 Global Bio-Pharma Key Vendors Revenue
Figure 2020-2025 Global Bio-Pharma Market Size and Growth Rate
Table 2020-2025 Global Bio-Pharma Key Vendors Market Share
Table 2020-2025 Global Bio-Pharma Market Size by Type
Table 2020-2025 Global Bio-Pharma Market Share by Type
Table 2025-2030 Global Bio-Pharma Market Size by Region
Table 2025-2030 Global Bio-Pharma Market Size Share by Region
Table 2025-2030 Global Bio-Pharma Market Size by Application
Table 2025-2030 Global Bio-Pharma Market Share by Application
Table 2025-2030 Global Bio-Pharma Key Vendors Revenue
Figure 2025-2030 Global Bio-Pharma Market Size and Growth Rate
Table 2025-2030 Global Bio-Pharma Key Vendors Market Share
Table 2025-2030 Global Bio-Pharma Market Size by Type
Table 2025-2030 Bio-Pharma Global Market Share by Type

Companies Mentioned

  • AstraZeneca
  • Eli Lilly
  • Bayer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novartis Merck & Co.
  • Bristol-Myers Squibb
  • Pfizer
  • AbbVie
  • Roche
  • Sanofi
  • Amgen
  • Biogen